Bioinformatic profiling identifies a platinum-resistant-related risk signature for ovarian cancer. [electronic resource]
Producer: 20210426Description: 1242-1253 p. digitalISSN:- 2045-7634
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Biomarkers, Tumor -- genetics
- Computational Biology
- Cystadenocarcinoma, Serous -- drug therapy
- Datasets as Topic
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Models, Genetic
- Oligonucleotide Array Sequence Analysis -- statistics & numerical data
- Organoplatinum Compounds -- pharmacology
- Ovarian Neoplasms -- drug therapy
- Phosphatidylinositol 3-Kinases -- metabolism
- Prognosis
- Progression-Free Survival
- RNA, Messenger
- ROC Curve
- Transcriptome -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.